Key result
Novel hPSC-derived cardiac organoid platform models epicardial interactions to generate heterogeneous cardiac fibroblasts.
Why the study?
Cardiac fibroblasts are essential in heart development and implicated in disease progression, but platforms to study their development, maturation, and heterogeneity remain needed.
A novel hPSC-derived organoid model successfully recapitulates human cardiac fibroblast specification and heterogeneity, providing a platform for studying cardiovascular development and fibrosis.
Answers are grounded in this paper and cite their sources.
Provides a scalable in vitro system for fibroblast heterogeneity studies; hypothesis-generating until validated in human disease models.
Abstract (Summary) Cardiac fibroblasts play an essential role in the development of the heart and have been implicated in disease progression in the context of fibrosis and regeneration. Here, we established a simple organoid culture platform using human pluripotent stem cell-derived epicardial cells and ventricular cardiomyocytes to study cardiac fibroblasts’ development, maturation and heterogeneity under normal conditions and following treatment with pathological stimuli. We demonstrated that this system models the early interactions between epicardial cells and cardiomyocytes to generate a population of fibroblasts that recapitulates many aspects of fibroblast behaviour in vivo including changes associated with maturation and in response to pathological stimuli associated with cardiac injury. Using single cell transcriptomics, we show that the hPSC-derived organoid fibroblast population displays a high degree of heterogeneity that approximates the heterogeneity of populations in both the normal and diseased human heart. Additionally, we identified a unique subpopulation of fibroblasts possessing reparative features previously characterized in the hearts of model organisms. Taken together, our system recapitulates many aspects of human cardiac fibroblast specification, development and maturation providing a platform to investigate the role of these cells in human cardiovascular development and disease.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2023) studied Cardiac fibroblast development and heterogeneity. hPSC-derived epicardial cells and ventricular cardiomyocytes organoid culture vs. Ventricular cardiomyocyte aggregates without epicardial cells was evaluated on Cardiomyocyte proliferation and epicardial epithelial-to-mesenchymal transition (EMT). An organoid culture platform using hPSC-derived epicardial cells and ventricular cardiomyocytes successfully modeled early interactions to generate a heterogeneous population of cardiac fibroblasts.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: